Article info
PDFHepatology
Original research
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
- Correspondence to Professor Young-Suk Lim, Department of Gastroenterology, Asan Medical Center, Songpa-gu, Seoul, Korea (the Republic of); limys{at}amc.seoul.kr; Professor Eui-Kyung Lee, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea; ekyung{at}skku.edu
Citation
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
Publication history
- Received April 3, 2020
- Revised October 15, 2020
- Accepted November 7, 2020
- First published November 25, 2020.
Online issue publication
October 07, 2021
Article Versions
- Previous version (25 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.